Ledger.Open graph →
SEC Form D · Amendment · filed July 20, 2017

Nacuity Pharmaceuticals, Inc

Offering
$10.0M
Sold
$9.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
FORT WORTH, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Martin Devenney · Milpitas, CAExecJohn M. Nehra · Minneapolis, MNDirectorAndrew W. Midler · Santa Clara, CADirectorLewis C. Pell · Santa Clara, CAExecTodd M. Sakow · Tampa, FLDirectorSeth Levine · New York, NYExec · DirectorJamie M. Yoakum · Tampa, FLDirectorMichael A. Seton · Tampa, FLDirectorMike Weber · Uniondale, NYExec · DirectorChris Hopkins · Richmond, British Columbia, CanadaExecGreg B. Gibson · Richmond, British Columbia, CanadaDirectorLucas Stoioff · Chicago, ILDirectorDavid Rekhson · Chicago, ILExecErik D. Hagen · Oakbrook Terrace, ILDirectorJason J. Hagen · Oakbrook Terrace, ILDirectorTome J. Tomaj · Oakbrook Terrace, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗